semaglutide alcohol reduction GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute Semaglutide reduces alcohol intake and

Some studies link GLP-1 use to an increased risk for ocular diseases such as nonarteritic anterior ischemic optic neuropathy (NAION), diabetic retinopathy, papillitis, and optic nerve disorders

This product has Glutathione in its reduced, active form for optimum bioavailability and includes Milk Thistle Extract and Alpha-Lipoic Acid as complementary ingredients

GIP receptor activation has been proposed, based on preclinical and early human data, to further support insulin secretion and fat metabolism, whilst glucagon receptor agonism may promote energy expenditure and reduce hepatic fat accumulation

In 2025, global systemwide sales rose 7% to more than $139 billion, while loyalty-member sales increased 20% to nearly $37 billion across 70 markets

Compared to insulin, GLP-1RA medications were associated with a significantly lower risk of liver cancer (HR: 0.47, 95% CI: 0.270.82) and pancreatic cancer (HR: 0.23, 95% CI: 0.110.51)

Its essential for blood health and helps protect against some blood-related diseases, such as anemia